Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
10.38
-0.14
(-1.38%)
After-Hours: 20:00
Precision BioSciences Cash from Operations (Quarterly): -8.423M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -8.423M |
September 30, 2023 | -23.09M |
June 30, 2023 | -21.13M |
March 31, 2023 | -31.46M |
December 31, 2022 | -21.84M |
September 30, 2022 | 29.19M |
June 30, 2022 | -24.22M |
March 31, 2022 | -28.87M |
December 31, 2021 | -23.68M |
September 30, 2021 | -23.90M |
June 30, 2021 | -31.34M |
March 31, 2021 | 68.07M |
Date | Value |
---|---|
December 31, 2020 | -13.45M |
September 30, 2020 | -22.22M |
June 30, 2020 | -25.80M |
March 31, 2020 | -25.91M |
December 31, 2019 | -20.56M |
September 30, 2019 | -13.98M |
June 30, 2019 | -16.58M |
March 31, 2019 | -19.91M |
December 31, 2018 | -12.91M |
September 30, 2018 | -15.05M |
June 30, 2018 | -9.31M |
March 31, 2018 | -14.45M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-31.46M
Minimum
Mar 2023
68.07M
Maximum
Mar 2021
-14.70M
Average
-22.22M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
Altimmune Inc | -16.53M |
BioVie Inc | -5.910M |
Adial Pharmaceuticals Inc | -1.223M |
Gritstone Bio Inc | -19.51M |
Humacyte Inc | -19.05M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 0.042M |
Cash from Financing (Quarterly) | 2.828M |
Free Cash Flow | -86.39M |
Free Cash Flow Per Share (Quarterly) | -2.022 |
Free Cash Flow to Equity (Quarterly) | -8.465M |
Free Cash Flow Yield | -211.7% |